Imbria Pharmaceuticals, Inc.

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

• Alvin Shih — Executive Officer / Director, Boston, MA
• Andrew Levin — Director, Boston, MA
  4 other raises

  • Climb Bio, Inc. $110.1M of $110.1M · 100.0%
  • Slate Medicines, Inc. $10.0M of $130.0M · 7.7%
  • Lonestar Medicines, Inc. $25.0M of $45.0M · 55.6%
  • Pahr Therapeutics, Inc. $4.7M of $14.0M · 33.3%
• Luse Rebecca — Director, Boston, MA
• Charles Dunn — Director, Boston, MA
• Komal Joshi — Executive Officer, Boston, MA
• Pavan Cheruvu — Director, Boston, MA
• Ken Horne — Director, Boston, MA
  2 other raises

  • AN Venture Partners I, LP $197.0M of $197.0M · 100.0%
  • Pahr Therapeutics, Inc. $4.7M of $14.0M · 33.3%
• Zina Affas Besse — Director, Boston, MA
  2 other raises

  • Eyenuk, Inc. $5.6M of $5.6M · 99.3%
  • Axena Health, Inc. $15.0M of —

Placement agents

• No sales compensation reported — direct raise.